Financial Enhancement Group LLC Organovo Holdings, Inc. Transaction History
Financial Enhancement Group LLC
- $545 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding ONVO
# of Institutions
37Shares Held
885KCall Options Held
16.2KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA354KShares$265,2090.0% of portfolio
-
Black Rock Inc. New York, NY142KShares$106,6560.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny97.8KShares$73,3400.0% of portfolio
-
Geode Capital Management, LLC Boston, MA74.9KShares$56,1820.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il46.4KShares$34,7810.0% of portfolio
About ORGANOVO HOLDINGS, INC.
- Ticker ONVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,712,020
- Market Cap $6.53M
- Description
- Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...